Anticoagulant proteins from snake venoms: structure, function and mechanism
- 13 July 2006
- journal article
- review article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 397 (3), 377-387
- https://doi.org/10.1042/bj20060302
Abstract
Over the last several decades, research on snake venom toxins has provided not only new tools to decipher molecular details of various physiological processes, but also inspiration to design and develop a number of therapeutic agents. Blood circulation, particularly thrombosis and haemostasis, is one of the major targets of several snake venom proteins. Among them, anticoagulant proteins have contributed to our understanding of molecular mechanisms of blood coagulation and have provided potential new leads for the development of drugs to treat or to prevent unwanted clot formation. Some of these anticoagulants exhibit various enzymatic activities whereas others do not. They interfere in normal blood coagulation by different mechanisms. Although significant progress has been made in understanding the structure-function relationships and the mechanisms of some of these anticoagulants, there are still a number of questions to be answered as more new anticoagulants are being discovered. Such studies contribute to our fight against unwanted clot formation, which leads to death and debilitation in cardiac arrest and stroke in patients with cardiovascular and cerebrovascular diseases, arteriosclerosis and hypertension. This review describes the details of the structure, mechanism and structure-function relationships of anticoagulant proteins from snake venoms.This publication has 167 references indexed in Scilit:
- Analysis of Colubroidea snake venoms by liquid chromatography with mass spectrometry: evolutionary and toxinological implicationsRapid Communications in Mass Spectrometry, 2003
- Subunit Dissociation, Unfolding, and Inactivation of Bothrojaracin, a C-Type Lectin-like Protein from Snake VenomBiochemistry, 2002
- C-type lectin-like domainsCurrent Opinion in Structural Biology, 1999
- Allosteric Changes of Thrombin Catalytic Site Induced by Interaction of Bothrojaracin with Anion-Binding Exosites I and IIBiochemical and Biophysical Research Communications, 1999
- Crystal structure of coagulation factor IX-binding protein from habu snake venom at 2.6 å: implication of central loop swapping based on deletion in the linker regionJournal of Molecular Biology, 1999
- Defibrinogenating EnzymesDrugs, 1997
- Isolation and Characterization of Carinactivase, a Novel Prothrombin Activator in Echis carinatus Venom with a Unique Catalytic MechanismOnline Journal of Public Health Informatics, 1996
- Structure—function relationships in the receptor for urokinase‐type plasminogen activator Comparison to other members of the Ly‐6 family and snake venom α‐neurotoxinsFEBS Letters, 1994
- .kappa.-Bungarotoxin: complete amino acid sequence of a neuronal nicotinic receptor probeBiochemistry, 1985
- Assignment of the 1H nuclear magnetic resonance spectrum of the trypsin inhibitor homologue K from Dendroaspis polylepis polylepis: Two-dimensional nuclear magnetic resonance at 360 and 500 MHzJournal of Molecular Biology, 1983